Virogin Biotech Ltd.
Clinical trials sponsored by Virogin Biotech Ltd., explained in plain language.
-
Engineered herpes virus takes aim at Hard-to-Treat cancers
Disease control Not yet recruitingThis study tests a new treatment called VG2025, a modified herpes simplex virus designed to infect and kill cancer cells while also boosting the immune system. The trial enrolls adults with advanced solid tumors that have not responded to standard therapies and who have previousl…
Phase: PHASE1, PHASE2 • Sponsor: Virogin Biotech Ltd. • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Modified herpes virus takes on bile duct cancer in new trial
Disease control Not yet recruitingThis phase 2 trial tests VG2025, a modified herpes virus that targets and kills cancer cells while boosting the immune system, in 30 people with advanced intrahepatic cholangiocarcinoma (a type of bile duct cancer). The virus is injected directly into tumors every four weeks. Ear…
Phase: PHASE2 • Sponsor: Virogin Biotech Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC